Stivarga (regorafenib)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
June 2016
WARNINGS AND PRECAUTIONS
Hepatotoxicity
Severe drug-induced liver injury with fatal outcome occurred in...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts